Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohan Doss

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2010
Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatmentSmitha Reddy, Calvin C Shaller, Mohan Doss, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2016
Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET RadiotracersJimson W D'Souza, Harvey Hensley, Mohan Doss, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 3, 2012
Impact of expression system on the function of the C6.5 diabody PET radiotracerJoshua Miller, Mohan Doss, Ryan McQuillen, et al.
Cancer Research|March 1, 2005
Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabodyMatthew K Robinson, Mohan Doss, Calvin Shaller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scannerDinko E González Trotter, Ravindra M Manjeshwar, Mohan Doss, et al.
International Journal of Occupational Medicine and Environmental Health|February 9, 2018
Letter to the Editor (August 24, 2017) concerning the paper "Occupational exposure to radon for underground tourist routes in Poland: Doses to lung and the risk of developing lung cancer"S M Javad Mortazavi, Joseph John Bevelacqua, Krzysztof W Fornalski, et al.
Nuclear Medicine Communications|October 16, 2010
Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CTMohan Doss, James J Zhang, Marie-José Bélanger, et al.
Dose-Response : a Publication of International Hormesis Society|June 10, 2014
Commentary: ethical issues of current health-protection policies on low-dose ionizing radiationYehoshua Socol, Ludwik Dobrzyński, Mohan Doss, et al.
Molecular Imaging and Biology|April 4, 2014
Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2010
Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatmentSmitha Reddy, Calvin C Shaller, Mohan Doss, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2016
Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET RadiotracersJimson W D'Souza, Harvey Hensley, Mohan Doss, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 3, 2012
Impact of expression system on the function of the C6.5 diabody PET radiotracerJoshua Miller, Mohan Doss, Ryan McQuillen, et al.
Cancer Research|March 1, 2005
Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabodyMatthew K Robinson, Mohan Doss, Calvin Shaller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scannerDinko E González Trotter, Ravindra M Manjeshwar, Mohan Doss, et al.
International Journal of Occupational Medicine and Environmental Health|February 9, 2018
Letter to the Editor (August 24, 2017) concerning the paper "Occupational exposure to radon for underground tourist routes in Poland: Doses to lung and the risk of developing lung cancer"S M Javad Mortazavi, Joseph John Bevelacqua, Krzysztof W Fornalski, et al.
Nuclear Medicine Communications|October 16, 2010
Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CTMohan Doss, James J Zhang, Marie-José Bélanger, et al.
Dose-Response : a Publication of International Hormesis Society|June 10, 2014
Commentary: ethical issues of current health-protection policies on low-dose ionizing radiationYehoshua Socol, Ludwik Dobrzyński, Mohan Doss, et al.
Molecular Imaging and Biology|April 4, 2014
Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.
Pageof 7